1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
Barata PC and Rini BI: Treatment of renal
cell carcinoma: Current status and future directions. CA Cancer J
Clin. 67:507–524. 2017. View Article : Google Scholar : PubMed/NCBI
|
3
|
Muller UC, Deller T and Korte M: Not just
amyloid: Physiological functions of the amyloid precursor protein
family. Nat Rev Neurosci. 18:281–298. 2017. View Article : Google Scholar : PubMed/NCBI
|
4
|
Shariati SA and De Strooper B: Redundancy
and divergence in the amyloid precursor protein family. FEBS Lett.
587:2036–2045. 2013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Pandey P, Rachagani S, Das S,
Seshacharyulu P, Sheinin Y, Naslavsky N, Pan Z, Smith BL, Peters
HL, Radhakrishnan P, et al: Amyloid precursor-like protein 2
(APLP2) affects the actin cytoskeleton and increases pancreatic
cancer growth and metastasis. Oncotarget. 6:2064–2075. 2015.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Pandey P, Sliker B, Peters HL, Tuli A,
Herskovitz J, Smits K, Purohit A, Singh RK, Dong J, Batra SK, et
al: Amyloid precursor protein and amyloid precursor-like protein 2
in cancer. Oncotarget. 7:19430–19444. 2016. View Article : Google Scholar : PubMed/NCBI
|
7
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C (T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: the 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Fuhrman SA, Lasky LC and Limas C:
Prognostic significance of morphologic parameters in renal cell
carcinoma. Am J Surg Pathol. 6:655–663. 1982. View Article : Google Scholar : PubMed/NCBI
|
10
|
Arvidsson Y, Andersson E, Bergström A,
Andersson MK, Altiparmak G, Illerskog AC, Ahlman H, Lamazhapova D
and Nilsson O: Amyloid precursor-like protein 1 is differentially
upregulated in neuroendocrine tumours of the gastrointestinal
tract. Endocr Relat Cancer. 15:569–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
11
|
Lim S, Yoo BK, Kim HS, Gilmore HL, Lee Y,
Lee HP, Kim SJ, Letterio J and Lee HG: Amyloid-beta precursor
protein promotes cell proliferation and motility of advanced breast
cancer. BMC Cancer. 14:9282014. View Article : Google Scholar : PubMed/NCBI
|
12
|
Peters HL, Tuli A, Wang X, Liu C, Pan Z,
Ouellette MM, Hollingsworth MA, Macdonald RG and Solheim JC:
Relevance of amyloid precursor-like protein 2 C-terminal fragments
in pancreatic cancer cells. Int J Oncol. 41:1464–1474. 2012.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Jiang L, Yu G, Meng W, Wang Z, Meng F and
Ma W: Overexpression of amyloid precursor protein in acute myeloid
leukemia enhances extramedullary infiltration by MMP-2. Tumour
Biol. 34:629–636. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Venkataramani V, Thiele K, Behnes CL, Wulf
GG, Thelen P, Opitz L, Salinas-Riester G, Wirths O, Bayer TA and
Schweyer S: Amyloid precursor protein is a biomarker for
transformed human pluripotent stem cells. Am J Pathol.
180:1636–1652. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Cojocaru E, Lozneanu L, Giuşcă SE, Căruntu
ID and Danciu M: Renal carcinogenesis-insights into signaling
pathways. Rom J Morphol Embryol. 56:15–19. 2015.PubMed/NCBI
|
16
|
Sandbrink R, Masters CL and Beyreuther K:
Similar alternative splicing of a non-homologous domain in beta
A4-amyloid protein precursor-like proteins. J Biol Chem.
269:14227–14234. 1994.PubMed/NCBI
|
17
|
Meng JY, Kataoka H, Itoh H and Koono M:
Amyloid beta protein precursor is involved in the growth of human
colon carcinoma cell in vitro and in vivo. Int J Cancer. 92:31–39.
2001. View Article : Google Scholar : PubMed/NCBI
|
18
|
Peters HL, Tuli A, Sharma M, Naslavsky N,
Caplan S, MacDonald RG and Solheim JC: Regulation of major
histocompatibility complex class I molecule expression on cancer
cells by amyloid precursor-like protein 2. Immunol Res. 51:39–44.
2011. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mehdi A and Riazalhosseini Y: Epigenome
aberrations: Emerging driving factors of the clear cell renal cell
carcinoma. Int J Mol Sci. 18:E17742017. View Article : Google Scholar : PubMed/NCBI
|